Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioLine RX Ltd (NASDAQ:BLRX)

0.7785
Delayed Data
As of Jul 29
 +0.0145 / +1.90%
Today’s Change
0.71
Today|||52-Week Range
1.88
-40.12%
Year-to-Date
Institutional investors liquidated a net -- shares of BLRX during the quarter ended --, and now own 13.45% of shares outstanding, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Other institutional12.61%
Mutual fund holders0.84%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

5/31/2016APO ASSET MANAGEMENT GMBH  Sold 127.5 Thousand shares of BioLine RX Ltd

Top 10 Owners of BioLine RX Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Senvest Management LLC6.28%3,543,3002,834,640-60,000-1.67%
OrbiMed Advisors LLC1.84%1,038,600830,88000.00%
Alyeska Investment Group LP1.06%599,530479,624+154,792+34.81%
Millennium Management LLC0.89%500,000400,000-100,000-16.67%
Morgan Stanley & Co. LLC0.76%428,458342,766-24,500-5.41%
Opaleye Management, Inc.0.44%250,000200,00000.00%
Oppenheim Asset Management Servic...0.43%243,696194,95700.00%
Apo Asset Management GmbH0.39%219,085175,268-127,498-36.79%
Medical Strategy GmbH0.37%209,490167,59200.00%
KCG Americas LLC0.24%135,343108,274+135,343--

Top 10 Mutual Funds Holding BioLine RX Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
FCP OP Medical BioHe@lth-Trends0.37%209,490167,59200.00%
APO Medical Opportunities0.25%142,457113,966-127,498-47.23%
APO Medical Opportunities Institu...0.14%76,62861,30200.00%
Pharma/wHealth Fund0.06%34,20627,36500.00%
RIM Global - Bioscience0.02%12,4009,920-46,800-79.05%